|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$4.55 |
$4.55 |
$4.25 |
$4.36 |
6.40K | 03/25/2024 |
$4.59 |
$5.33 |
$3.73 |
$3.78 |
132.70K | 03/26/2024 |
$3.73 |
$4.32 |
$3.51 |
$4.02 |
39.50K | 03/27/2024 |
$4.14 |
$4.14 |
$4.00 |
$4.04 |
11.40K | 03/28/2024 |
$4.14 |
$4.24 |
$4.01 |
$4.12 |
46.10K |
|
Bio-Path Holdings is a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company utilizing a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Co.'s primary drug candidate, prexigebersen, which targets growth factor receptor-bound protein 2, initially started the efficacy portion of a Phase 2 clinical trial for untreated acute myeloid leukemia patients. Co.'s second drug candidate, Liposomal Bcl-2, targets the protein Bcl-2, which is responsible for driving cell survival in up to 60% of all cancers. Co.'s third drug candidate, Liposomal STAT3, targets the STAT3 protein. | |
|
Bio-Path Holdings (BPTH) has the following price history information. Looking back at BPTH historical stock prices for the last five trading days, on March 22, 2024, BPTH opened at $4.55, traded as high as $4.55 and as low as $4.25, and closed at $4.36. Trading volume was a total of 6.40K shares. On March 25, 2024, BPTH opened at $4.59, traded as high as $5.33 and as low as $3.73, and closed at $3.78. Trading volume was a total of 132.70K shares. On March 26, 2024, BPTH opened at $3.73, traded as high as $4.32 and as low as $3.51, and closed at $4.02. Trading volume was a total of 39.50K shares. On March 27, 2024, BPTH opened at $4.14, traded as high as $4.14 and as low as $4.00, and closed at $4.04. Trading volume was a total of 11.40K shares. On March 28, 2024, BPTH opened at $4.14, traded as high as $4.24 and as low as $4.01, and closed at $4.12. Trading volume was a total of 46.10K shares.
BPTH Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bio-Path Holdings shares, starting with a $10,000 purchase of BPTH, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$9,040.00 |
|
End price/share: |
$4.12 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.95% |
|
Average Annual Total Return: |
-53.68% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4.56 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $4.36 | 03/25/2024 | $3.78 | 03/26/2024 | $4.02 | 03/27/2024 | $4.04 | 03/28/2024 | $4.12 |
|
|